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A B S T R A C T
Purpose: The epilepsy treatment gap in resource-poor countries is so large that existing numbers of
doctors are unlikely to be able to close it. Other health workers are likely to be needed but they will need
help. The diagnosis of an attack as epileptic or not is an essential step in the management of epilepsy. It
should be possible to devise a tool to give the probability of episodes being epileptic based on a Bayesian
analysis of the results of history taking.
Method: We asked about the nature of episodes in patients referred to epilepsy camps in Nepal. Answers
were then compared to the ﬁnal clinical diagnosis of epilepsy and the likelihood ratio (LR) of the episode
being epileptic obtained for each answer. The most informative LRs, tested sequentially, formed the basis
for a tool which was validated in a different Nepalese population.
Results: Data was obtained from 67 patients. The pre-test probability of having epilepsy was 0.76.
Answers to 11 questions with the most informative LRs were then combined into a tool. This was tested
on 14 different patients. Post-test probability scores in those with epilepsy ranged from 0.88 to 1 and for
those with non-epilepsy from 0.07 to 0.42.
Conclusion: It is possible to devise a tool based on simple clinical information using Bayesian principles.
Initial validation suggests that this has the potential to enable health workers to diagnose episodes as
epileptic or not. This now needs to be tested in different populations. The tool is easily converted to a
mobile phone app.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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There are not enough doctors to treat people with untreated
epilepsy so if the epilepsy treatment gap in the developing world is
to be closed then other health professionals must be involved with
epilepsy management.1 To do this they will need help. The
diagnosis of episodes of altered consciousness as epileptic seizures
is one important part of the management of epilepsy. This is
traditionally done by doctors and is relatively time-consuming. It
relies on asking questions and interpreting the replies, a process
which is no different in the developing world than in the
industrialised one.2 It should be possible to design a tool to doAbbreviations: ES, epileptic seizures; NES, not epileptic seizures; LR, likelihood
ratio.
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diagnostic process. This would enable the diagnosis to be made
by non-doctors and save precious medical time. The information
necessary to develop this tool was available to us from a previous
study from Nepal in which we trained non-neurologists to
diagnose epilepsy.3
2. Methods
2.1. Location
Dhulikhel Hospital is located east of Kathmandu in Nepal. It was
founded in 1994 as a not-for-proﬁt non-governmental institution
serving its local community. It has since grown to a 370-bed
hospital and has become the major teaching hospital for
Kathmandu University School of Medicine. It serves a predomi-
nantly rural population and also runs outreach centres in the
surrounding countryside.served.
Table 1
Questions asked.
Name Any stiffness?
Date Any shaking?
Clinic Total minutes of abnormal movement
Clinic number Are eyes open or closed?
Age Can you communicate when stiff/shaking?
Sex After stiffness/shaking stops
how long before starts to come round?
Village Total minutes till normal
Mobile Does head turn to right or left?
Occupation Any incontinence?
Travel time to clinic in hours Any tongue biting?
Can read Nepali Are you sleepy or confused afterwards?
Is this your ﬁrst attendance
for these blackouts?
Are your muscles sore?
Age at ﬁrst attack Is one arm or leg weak afterwards?
How many attacks? If so which?
How many in last month? Predisposing factors
How many days since attack? If Family history how many affected?
Time of attacks Other illnesses
Attacks lying down Other drugs
Precipitating factors1 IF SEEN BEFORE, Year ﬁrst seen
Precipitating factors2 EEG
Any warning1? CT
Any warning2? MRI
How many minutes for? Present drug1
Do these ever occur without
an attack?
Dose
How many in last month? Present drug2
Eyewitness present? Dose
What happens ﬁrst? Present drug3
Any colour change? Dose
Table 2
Variables with likelihood ratios > 3 of episodes either being epileptic seizures (F) or
not epileptic seizures (A).
Prior to the episode Male gender (F)
Predisposing factors excluding family history (F)
During the episode Colour change to red or blue (F)
Stiffness (F)
Shaking (F)
Tongue bitten (F)
Incontinence of urine (F)
Head turning to one side (F)
Eyes closed (A)
Able to communicate (A)
After the episode One-sided weakness (F)
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A visiting neurologist (VP) performed special clinics for people
with suspected epilepsy at both the hospital and some of these
outreach centres. These camps were advertised as widely as
possible during the preceding weeks using local notices, news-
papers, local radio and word-of-mouth.
2.3. Initial consultation model
The neurologist was accompanied by a local physician (PP), and
an intern doctor (NG) who acted as interpreters, translating the
history from Nepali into English for VP. If epilepsy was possible
then predetermined questions were asked about the nature of the
episodes.3 These questions were grouped around broad themes:
demography, events preceding the episode, eyewitness description
of the episode when available, events following the episode and
predisposing factors (Table 1).
2.4. Patients and clinical diagnosis
Children under nine years old were excluded because of the
possibility of signiﬁcant differences in clinical seizure presentation
in younger children. At the end of the history, the neurologist made
a clinical diagnosis of the presenting episodes which was
expressed as epileptic seizures (ES), not epileptic seizures (NES),
single seizure or uncertain.
For the rest of the analysis the last two categories were
excluded.
2.5. Likelihood ratios
For each variable the likelihood of having epileptic seizures (ES)
and not having epileptic seizures (NES) was calculated as a
likelihood ratio (LR).4 The variables with the most signiﬁcant LRs
were then selected for the validation phase.2.6. Validation
This was carried out on a different population of patients but at
the same locations. The diagnosis of ES, NES or uncertainty was
again made by the neurologist on clinical grounds. During the
course of history taking the answers to each of the previously
selected questions was entered on a spreadsheet by the translating
intern (AB) and a ﬁnal probability score of ES obtained. The
neurologist was not aware of this probability until he had reached
his own clinical diagnosis.
3. Results
3.1. Pre-test probability
A total of 72 patients were seen. Five were excluded from
analysis, three because the diagnosis was uncertain and two who
had single seizures. This left a study population of 67.
Fifty-one of these had ES and 16 NES giving a pre-test
probability of having ES of 0.76. The most common diagnosis in
those patients with NES was non-epileptic attack disorder. Forty-
seven of those with ES had convulsive (tonic–clonic) seizures and
four had non-convulsive (partial) seizures only.
3.2. Likelihood ratios
The LR for the episodes either being ES or NES based on the
presence or absence of a variable was then calculated for each
variable. If, in calculating the LR, a zero value in the denominator
was encountered, this was dealt with by adding 1 to that one value
rather than adding 0.5 to each value in the 2  2 table as in the
correction devised by Cox.5 This had a conservative effect on the
size of LRs.
3.3. Relevant answers
The reciprocal was taken of those LRs less than one (in favour of
NES) to compare the magnitude of the effect of each LR. In this way
eleven questions had a magnitude greater than three and were
then selected for further evaluation. These are shown in Table 2.
3.4. Development of a Bayesian model
The relevant questions were ordered on a logical basis for
history taking with gender and predisposing factors ﬁrst, then
events in the attack and ﬁnally post-ictal weakness. The pre-test
probability of 0.76 was altered by the LR for gender to give a post-
test probability. This then became the pre-test probability for the
next question, predisposing factors, resulting in a post-test
probability. This process was repeated for the remaining nine
questions after which a ﬁnal probability score for that person
having ES was obtained.
Fig. 1. Probability score of having ES derived from tool in patients with three
different diagnoses.
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Fourteen people made up this population. The clinical diagnosis
of ES was made in 10, NES in three and in one the diagnosis was
uncertain. Of those with ES, eight were convulsive and two non-
convulsive – one with head turning and asymmetric limb
posturing and the other with running. These had probability
scores of ES of 0.89 and 0.88 respectively.
For ES the mean probability was 0.97, range 0.88–1.0. For NES
mean was 0.3, range 0.07–0.42. The clinically uncertain case had a
probability of 1.0. Probability scores are plotted for each clinical
diagnosis in Fig. 1.
4. Discussion
It is therefore possible to design a tool to diagnose episodes of
altered consciousness as epileptic or not. This tool is based on
Bayesian principles and mirrors the way in which physicians make
the diagnosis of epilepsy except that they do it intuitively based on
their previous experience. Their advantage over a tool is being able
to access a range of contextual information and non-verbal
communication in coming to their conclusion but with the
disadvantage of sometimes bringing their own emotions into
the diagnosis – for example, being reluctant to classify an attack as
epileptic because they know that this would have a much more
drastic effect on someone whose occupation depends on driving a
vehicle than a non-epileptic diagnosis would. This tool is devoid of
such emotion. It is based simply on the acquired and recorded
experience gleaned from 67 people with episodic alteration or loss
of consciousness; most neurologists will have seen, considerably
more patients than this, but health workers who are the ﬁrst (and
sometimes the only) point of contact for people with epilepsy in
much of the world will have seen less. It is for these people that we
have developed this tool although it may well be useful for less-
experienced doctors.
Using 11 eloquent variables avoids the overdependence on
single symptoms, none of which is invariably correct in making or
excluding a diagnosis of an epileptic seizure. It also lessens the
effect of the intrinsic unreliability present in giving a history of
remote events.A similar approach has been used to separate syncope from
epilepsy.6 This was developed in tertiary referral clinics in
resource-rich countries and is unlikely to be relevant to presenta-
tions in the resource-poor world.
Perhaps the most surprising inclusion in the tool was being
male with an LR of 9.73. This was due to the presence of non-
epileptic attack disorder within the group of people whose attacks
were NES, almost all of them female.
Although the tool was validated in only 14 people the
separation between ES and NES was very clear. Importantly the
two people with partial (non-convulsive) seizures had high
probabilities of epilepsy. Forty-seven of our 51 patients on whom
the tool was developed had convulsive (tonic–clonic) seizures, in
common with seizures patterns throughout the less-developed
world, so it was encouraging that these non-convulsive seizures
had probabilities much closer to ES than NES.
The gold-standard in epilepsy diagnosis is the opinion of a
neurologist. In this case having more than one neurologist was not
possible. All we can say to suggest a probable high degree of
accuracy is that the neurologist (VP) has had over 30 years
experience in a busy neurological practice in the UK health service,
has developed epilepsy services within that, has contributed to
multicentre studies on epilepsy management and is a member of
the International League Against Epilepsy’s Faculty of 1000.
The tool has been developed and tested in one region of one
resource-poor country and there may be differences in how
epileptic attacks present or are described in other parts of the
resource-poor world and certainly in the developed world. There
may also be different pre-test probabilities in different parts of the
world and a different spectrum of conditions contributing to NES.
Of the variables in the tool, only colour change to red or blue may
not be easily transferable to regions with very dark skin colours.
Another possible shortcoming is unwitting interdependence of
the variables used in the tool. This is certainly not obvious but
Bayes theorem requires that the variables tested are truly
independent of each other.7
So clearly this tool must be evaluated in other areas where the
epilepsy treatment gap is large. This is underway with the tool
embedded in a mobile phone app.
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